Ferring Pharmaceuticals has launched Noqdirna in the UK, offering the only licensed treatment for the symptomatic treatment of nocturia due to nocturnal polyuria in adults of all ages. Nocturia is a ...

Women worldwide who count on Ferring Pharmaceutical’s flagship fertility drug may be out of luck for the foreseeable future. Ferring Pharmaceuticals has paused global shipments of the injectable ...

SAINT PREX, Switzerland, April 21, 2025--Ferring Pharmaceuticals presented the first results from an ongoing Phase 3 trial in Japan assessing the efficacy and safety of nadofaragene firadenovec in ...